** Shares of drugmaker Fennec Pharmaceuticals FENC.O rise 3.3% to $6.47

** Company reports Q1 sales rose 18% to $8.8 million, compared with analysts' estimates of $8.2 million - data compiled by LSEG

** Company posts quarterly net loss of 4 cents per share vs estimated loss of 9 cents per share

** As of last close, stock down 0.8% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))